69 Best Health Tech Startups to Watch in 2024
How do we build this list? TLDR: Using math and experts.
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
Sign up to Seedtable Intel to access the entire database
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. |
$120M · Series B | TCG Crossover, Atlas Ventures, Brandon Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
Contraceptive app for women. |
$55M · Series C | Heartcore, Point72 Ventures, Lauxera Capital Partners | 51 to 100 | Health Tech, Mobile | SaaS, B2C | Stockholm, Sweden | •••••••••••@naturalcycles.com | |
Developer of treatment for diffuse tenosynovial giant cell tumors. |
$75M · Series B | Bioqube Ventures, Medicxi, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech | B2B | Dublin, Ireland | •••••••••••@synoxtherapeutics.com | |
Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases. |
$139M · Series B | Nextech Invest, EQT Life Sciences, Andera Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Munich, Germany | •••••••••••@tubulis.com | |
Provider of single and multi-organ microphysiological systems. |
$21M · Series B | CN Innovations | 101 to 250 | Health Tech, Biotech | London, UK | •••••••••••@cn-bio.com | ||
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Mental health insurance platform. |
$20M · Series B | UNIQA Ventures, FinTLV Ventures, Korelya Capital | 251 to 500 | Health Tech, Insuretech | SaaS, B2C | Madrid, Spain | •••••••••••@ifeelonline.com | |
Digital healthcare solution provider for insurers, employers and educators. |
$18M · Series B | Act Venture Capital | 251 to 500 | Health Tech | B2B, SaaS | Dublin, Ireland | •••••••••••@spectrum.life | |
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Gene-editing platform. |
$30M · Series B | Khosla Ventures, Sanofi Ventures, Bpifrance | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@eligo.bio | ||
Immunotherapies developer for cancer patient. |
$4M · Seed | Fournier-Majoie, France 2030, Elaia | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@hephaistos-pharma.fr | ||
Precision oncology treatments developer. |
$21M · Series A | V-Bio Ventures | 1 to 10 | Health Tech, Biotech | Amsterdam, Netherlands | •••••••••••@flindrtx.com | ||
Developer of next-generation T cells against solid tumors. |
$9M · Seed | Brandenburg Kapital, i&i Biotech Fund | 1 to 10 | Health Tech, Biotech | Berlin, Germany | •••••••••••@captaintcell.com | ||
Antibody-drug conjugates (ADCs) developer for the treatment of cancer. |
$17M · Series A | RA Capital Management, Novo A/S, HealthCap | 11 to 50 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@adcendo.dk | |
Workflow automation platform for the life sciences industry. |
$40M · Series B | Local Globe, A.P. Moller Holding, Dimension | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Technology-enabled company providing home care services in London. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
Innovative heart pumps manufacturer. |
$28M · Series C | Bpifrance, Sofinnova Partners, Ysios Capital | 51 to 100 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@corwave.com | |
AI software for radiologists. |
$29M · Series B | Bpifrance, Heal Capital, Elaia | 1 to 10 | Health Tech, AI | B2B | Paris, France | •••••••••••@gleamer.ai | |
Biotechnology firm focused on life science advancements. |
$89M · Series A | Sofinnova Partners | 101 to 250 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@mnemo-tx.com | |
Robots for surgery. |
$55M · Series B | Sofinnova Partners, Cathay Innovation | 11 to 50 | Health Tech, Hardware, Deep Tech, Robotics, Manufacturing | B2B | Paris, France | •••••••••••@moonsurgical.com | |
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
Platform enabling small and medium enterprises to effortlessly pay their employees. |
$79M · Series C | Accel, Eurazeo | 251 to 500 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@payfit.com | |
AI-powered wound care monitoring platform. |
$3M · Seed | Bpifrance, Elaia, 50 Partners | 11 to 50 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@pixacare.com | |
Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases. |
$52M · Series A | Ysios Capital | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@sparingvision.com | |
Developer of digital health and wellness devices like fitness trackers and watches. |
$60M · Series B | 2050 | 101 to 250 | Health Tech, Hardware, Sportstech, Mobile, Manufacturing, Wearables | B2B | Paris, France | •••••••••••@withings.com | |
Preventative health care platform. |
$65M · Series A | General Catalyst, Atomico, Lakestar | 11 to 50 | Health Tech | B2C | Stockholm, Sweden | •••••••••••@nekohealth.com | |
Mechatronic guidewires manufacturer. |
$6M · Series A | Forepont Capital Partners, NTI Corporation | 11 to 50 | Health Tech, Hardware | B2B | Paris, France | •••••••••••@basecampvascular.com | |
4D cardiac imaging and navigation platform. |
$21M · Series A | EIC Accelerator, EQT Life Sciences, Atlantic Bridge University Fund | 11 to 50 | Health Tech | B2B, SaaS | Dublin, Ireland | •••••••••••@lumavision.com | |
AI platform to map the human immune system. |
$14M · Series A | Molten Ventures, Life Extension Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
Digital health platform for women. |
$5M · Seed | Blisce, Vorwerk Ventures | 1 to 10 | Health Tech | B2C, SaaS | Paris, France | •••••••••••@sorella-care.com | |
Biosensors developer to combat chronic kidney disease. |
$2M · Pre Seed | Bpifrance, Kima Ventures, Cenitz | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@metyos.com | ||
Advanced allosteric modulator therapeutics developer for neurological disorders. |
$63M · Series A | Xontogeny, Perceptive Advisors, Acorn Bioventures | 1 to 10 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@neurosterix.com | ||
Digital therapy platform for mental health treatment. |
$17M · Series A | TVM Capital Healthcare | 101 to 200 | Health Tech | B2C, SaaS | Munich, Germany | •••••••••••@neurocaregroup.com | |
AI-based platform for clinical trials. |
$2M · Seed | Bpifrance, Pfizer Healthcare Hub: London, Wilco | 1 to 10 | Health Tech, AI | B2B, SaaS | Paris, France | •••••••••••@klineo.fr | |
Wearable head sensor maker for vertigo treatment. |
$2M · Seed | Atlantic Bridge | 1 to 10 | Health Tech, Manufacturing | B2C | Dublin, Ireland | •••••••••••@vertigenius.com | |
Point-of-care diagnostic platform. |
$1M · Pre Seed | CentraleSupélec Venture | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@encarta.bio | ||
AI-powered platform for Alzheimer and dementia patients. |
$700k · Pre Seed | Abac Nest, Fondo Bolsa Social, Heartfelt | 1 to 10 | Health Tech, AI | B2C, SaaS | London, UK | •••••••••••@puntohealth.com | |
Clinical-stage biopharmaceutical company. |
$95M · Series A | Lightstone, GV, ARCH Venture Partners | 51 to 100 | Health Tech, Deep Tech | B2C | Dublin, Ireland | •••••••••••@carricktherapeutics.com | |
Ulltrasound-based medical devices manufacturer to treat various brain disorders. |
$4M · Series B | Unorthodox Ventures, EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Hardware | B2C | Paris, France | •••••••••••@carthera.eu | |
Innovative immunotherapies developer for cancer patients. |
$150M · Series D | Brandon Capital, Bioqube Ventures, Forbion Capital Partners | 11 to 50 | Health Tech, Biotech | B2B | Munich, Germany | •••••••••••@catalym.com | |
Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins. |
$50M · Series A | Khosla Ventures, General Catalyst | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
AI-driven services that aid healthcare providers in delivering timely, accurate care. |
$60M · Series B | Atomico, Eurazeo, Prosus & Naspers | 51 to 100 | Health Tech, Machine Learning | B2B, SaaS | Copenhagen, Denmark | •••••••••••@corti.ai | |
Biotechnology firm developing immunotherapies for cancer and autoimmune diseases. |
$46M | Bioqube Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@egle-tx.com | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
Platform that develops bio factories to treat significant eye diseases sustainably. |
$30M · Series B | Karista, Pureos Bioventures | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@eyevensys.com | |
Fertility treatment for employees. |
$6M · Seed | Notion Capital, Passion Capital, Tiny VC | 1 to 10 | Health Tech | B2B | London, UK | •••••••••••@fertifa.com | |
Community-driven living spaces designed and managed with technology and aesthetic appeal. |
$45M · Series C | High Rise Ventures, HV Capital, Deutsche Invest Equity Partners | 11 to 50 | Health Tech, Proptech & Real Estate, Community & Lifestyle | B2B, B2C | Berlin, Germany | •••••••••••@habyt.com | |
Software that simplifies daily tasks for healthcare professionals, allowing them to focus on patient care. |
$25M · Series A | Revaia, Acton Capital | 51 to 100 | Health Tech | B2B, SaaS | Paris, France | •••••••••••@hublo.com | |
Digital health platform for predictive care and research. |
$80M · Series D | Hitachi Ventures, Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@huma.com | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
Digital pet insurance platform. |
$25M · Series B | Balderton Capital, Felix Capital, Inventure | 1 to 10 | Health Tech, Pet Tech | B2C, Marketplace | Stockholm, Sweden | •••••••••••@lassie.co | |
Platform for simple and secure exchange of medical letters. |
$22M · Series B | Daphni, Partech Ventures, Serena | 11 to 50 | Health Tech, Hardware | B2B, SaaS | Paris, France | •••••••••••@lifen.fr | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Creandum, Seedcamp | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
Developer of prophylactic vaccine against Group B Streptococcus. |
$57M · Series C | EQT Partners, Novo A/S, OrbiMed | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@minervax.com | |
Digital care. Superpowered. Build engaging relationships with your patients through our machine learning-powered care platform. |
$20M | Firstminute Capital | 11 to 50 | Health Tech, AI, Mobile | B2C | Paris, France | •••••••••••@nabla.com | |
Oral macrocycle drug discovery platform. |
$28M · Seed | Novo A/S, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech | B2B | Copenhagen, Denmark | •••••••••••@orbismedicines.com | |
Manufacturing platform designed to help patients access lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Online platform providing residential assistance for seniors to help with daily activities at home. |
$31M · Series B | Future Positive Capital, XAnge | 51 to 100 | Health Tech | B2B, B2C, Marketplace | Paris, France | •••••••••••@ouihelp.fr | |
Behavior change platform digitizing the treatment of type 2 diabetes and obesity. |
$21M · Series B | Earlybird Venture Capital, AlbionVC, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
Cell therapy firm specializing in developing treatments using advanced cellular technology. |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
Platform optimizing clinical pathways between hospitals, care providers, and payers for better discharge management. |
$3M · Seed | Gilion | 51 to 100 | Health Tech | B2B, SaaS | Berlin, Germany | •••••••••••@recaresolutions.com | |
Lab automation robots manufacturer. |
$20M · Series A | R7 Partners, ACME Capital, Y Combinator | 11 to 50 | Health Tech, Robotics | B2B | Copenhagen, Denmark | •••••••••••@reshapebiotech.com | |
Biotechnology firm developing antiviral treatments for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Solution for protecting digestive anastomosis, designed to reduce complications. |
$47M | Sofinnova Partners | 1 to 10 | Health Tech, Hardware, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@safeheal.com | |
Cybersecurity platform. |
$37M · Series A | Northcap | 101 to 250 | Health Tech, Hardware, Cybersecurity, Manufacturing | B2B, SaaS | Paris, France | •••••••••••@sekoia.io | |
AI-powered prenatal screening solution. |
$14M · Series A | Bpifrance, Elaia, EIC Accelerator | 11 to 50 | Health Tech, Deep Tech | SaaS | Paris, France | •••••••••••@sonio.ai | |
Device providing non-invasive brain stimulation for treating depression and chronic pain. |
$5M · Series A | Verge HealthTech Fund, Voima Ventures | 1 to 10 | Health Tech | Helsinki, Finland | •••••••••••@soomamedical.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with – 2,473 in Health Tech.
Seedtable’s take on Health Tech
By Gonz Sánchez Sarmiento
CEO at Seedtable
Health Tech in Europe is a rapidly growing industry that is transforming medicine. Some of the trends powering this transformation include AI in healthcare, an increased focus on patient data, staff wellness, remote healthcare, and wearables. However, Europe is facing substantial challenges in continuing to deliver high-quality healthcare services to its citizens, including ageing populations, cultural shifts, rigid and complex financing models, increasing costs of innovation, a scarcity of skilled personnel, rising health inequalities, and health complexities stemming from climate change. The European Union has implemented the Regulation on Health Technology Assessment (HTA) to improve the quality of HTA across the Union and ensure an efficient use of resources. The European digital health market is predicted to grow at a CAGR of 27.1% from 2020 to 2025, with the UK, Germany, and France being the largest markets. The use of data and technology in the healthcare and life sciences sectors is expected to continue to enhance the industry, with artificial intelligence and machine learning playing a central role. However, the industry is fragmented, especially when it comes to rules and operational standards across the continent, making it challenging to establish a legal basis to allow the exchange of health data.
- Manufacturing... (2541)
- Health Tech... (2480)
- Fintech... (2445)
- Ecommerce... (1779)
- AI... (1630)
- Mobile... (1588)
- Data and Analytics... (1511)
- Business Intell...... (1461)
- Hardware... (1219)
- Climate Tech & ...... (1100)
- Energy & Nuclear... (1010)
- Biotech... (993)
- Mobility & Tran...... (948)
- Sales and Marke...... (947)
- Foodtech... (927)
- Proptech & Real...... (913)
- Deep Tech... (810)
- Media and Enter...... (787)
- Crypto & web3... (703)
- Edtech... (660)
- CPG & Consumer ...... (619)
- Developer Tools... (518)
- Privacy and Sec...... (515)
- Gaming... (497)
- Payments... (496)
- Machine Learning... (475)
- Hiring and Recr...... (473)
- Communications... (469)
- Fashion... (433)
- Community & Lif...... (405)
- Travel Tech... (392)
- Agritech... (389)
- Adtech... (374)
- Legal Tech... (358)
- Sportstech... (357)
- Cybersecurity... (295)
- Consumer Social... (293)
- Supply Chain & ...... (281)
- Video... (280)
- Pharma... (278)
- Robotics... (277)
- Productivity Tools... (257)
- Creative Tools... (256)
- Enterprise Soft...... (255)
- Insuretech... (231)
- CRM... (217)
- AR / VR... (214)
- Internet of Things... (213)
- Future of Work... (210)
- Music and Audio... (199)
- Fitness... (191)
- Cloud... (190)
- Service Industry... (162)
- Investing... (138)
- Food Delivery... (138)
- Space Tech... (137)
- Wearables... (111)
- Identity Manage...... (92)
- Navigation and ...... (84)
- Electric Vehicles... (81)
- Publishing... (77)
- ElderTech... (73)
- Govtech... (71)
- Semiconductor... (69)
- Personal Finance... (67)
- Art... (66)
- Drones... (66)
- Messaging... (63)
- Open Source... (57)
- IT Management... (53)
- Pet Tech... (51)
- Quantum Computing... (50)
- FamilyTech & Pa...... (44)
- Esports... (34)
- Genetics... (28)
- UK (462)
- Germany (259)
- France (274)
- Spain (155)
- Sweden (167)
- Switzerland (158)
- Netherlands (74)
- Italy (51)
- Denmark (94)
- Finland (68)
- Norway (37)
- Ireland (54)
- Belgium (43)
- Poland (45)
- Scotland (51)
- Austria (33)
- The Netherlands (23)
- London (253)
- Paris (135)
- Berlin (103)
- Stockholm (101)
- Copenhagen (79)
- Barcelona (72)
- Amsterdam (43)
- Munich (55)
- Madrid (40)
- Oslo (22)
- Helsinki (32)
- Zürich (47)
- Dublin (41)
- Milan (22)
- Cambridge (78)
- Vienna (30)
- Manchester (24)
- Brussels (25)
- Lyon (30)
- Glasgow (32)
- Geneva (26)
- Lausanne (40)
- Oxford (25)
- Basel (26)